Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J et al (2005). Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the ÆSOP study. Neuropsychopharmacology 30: 765–774.
Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B et al (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 58: 417–423.
Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ et al (2004). Pituitary volume in psychosis. Br J Psychiatry 185: 5–10.
Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C et al (2005). Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop First-Onset Psychosis Study. Neuropsychopharmacology, June 1 [Epub ahead of print].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pariante, C., Dazzan, P. Reply: Atypical Antipsychotics and Pituitary Size. Neuropsychopharmacol 31, 244–245 (2006). https://doi.org/10.1038/sj.npp.1300904
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300904